☰

Christine M. Ardito, Ph.D. - Publications

Affiliations: 
2011 Molecular and Cellular Pharmacology Stony Brook University, Stony Brook, NY, United States 
Area:
Cell Biology, Oncology, Molecular Biology
Tree Info Similar researchers PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Ardito CM, Grüner BM, Takeuchi KK, Lubeseder-Martellato C, Teichmann N, Mazur PK, Delgiorno KE, Carpenter ES, Halbrook CJ, Hall JC, Pal D, Briel T, Herner A, Trajkovic-Arsic M, Sipos B, et al. EGF receptor is required for KRAS-induced pancreatic tumorigenesis. Cancer Cell. 22: 304-17. PMID 22975374 DOI: 10.1016/J.Ccr.2012.07.024  0.346
2012 Halbrook CJ, Takeuchi KK, Ardito CM, Gruener BM, Siveke JT, Crawford HC. Abstract B84: EGFR activation by the ADAM17 sheddase is required for Kras-induced pancreatic tumorigenesis. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-B84  0.708
2012 Grüner B, Ardito C, Lubeseder-Martellato C, Briel T, Herner A, Mazur P, Schmid R, Crawford H, Siveke J. EGF Rezeptor signaling ist obligatorisch für die Kras-induzierte Entwicklung des Pankreaskarzinoms Zeitschrift FüR Gastroenterologie. 50. DOI: 10.1055/S-0032-1324047  0.467
2008 Ardito CM, Briggs CD, Crawford HC. Targeting of extracellular proteases required for the progression of pancreatic cancer. Expert Opinion On Therapeutic Targets. 12: 605-19. PMID 18410243 DOI: 10.1517/14728222.12.5.605  0.503
Show low-probability matches.